Preclinical Advance in Nanoliposome-mediated Photothermal Therapy in Liver Cancer

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Date 2025 Jan 31

PMID 39891269

Authors

Lixuan Tang

Xiao Yang

Liwen He

Chaogeng Zhu

Qingshan Chen

Affiliations

Soon will be listed here.

Abstract

Liver cancer is a highly lethal malignant tumor with a high incidence worldwide. Therefore, its treatment has long been a focus of medical research. Although traditional treatment methods such as surgery, radiotherapy, and chemotherapy have increased the survival rate of patients, their efficacy remains unsatisfactory owing to the nonspecific distribution of drugs, high toxicity, and drug resistance of tumor tissues. In recent years, the application of nanotechnology in the medical field has opened a new avenue for the treatment of liver cancer. Among these treatment methods, photothermal therapy (PTT) based on nanoliposomes has attracted wide attention owing to its unique targeting and high efficiency. This article reviews the latest preclinical research progress of nanoliposome-based PTT for liver cancer and its metastasis, discusses the preclinical challenges in this field, and proposes directions for improvement, with the aim of improving the effectiveness of liver cancer treatment.

Citing Articles

Correction: Preclinical advance in nanoliposomemediated photothermal therapy in liver cancer.

Tang L, Yang X, He L, Zhu C, Chen Q Lipids Health Dis. 2025; 24(1):60.

PMID: 39984950 PMC: 11844174. DOI: 10.1186/s12944-025-02481-1.

References

Siegel R, Giaquinto A, Jemal A . Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12-49. DOI: 10.3322/caac.21820. View

Huang K, Hsu F, Qiu J, Chern G, Lee Y, Chang C . Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Sci Adv. 2020; 6(3):eaax5032. PMC: 6962042. DOI: 10.1126/sciadv.aax5032. View

Makary M, Ramsell S, Miller E, Beal E, Dowell J . Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol. 2021; 27(43):7462-7479. PMC: 8613749. DOI: 10.3748/wjg.v27.i43.7462. View

Fong Z, Tanabe K . The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer. 2014; 120(18):2824-38. DOI: 10.1002/cncr.28730. View

Altekruse S, McGlynn K, Dickie L, Kleiner D . Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology. 2011; 55(2):476-82. PMC: 3868012. DOI: 10.1002/hep.24710. View

Kaffe E, Magkrioti C, Aidinis V . Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer. Cancers (Basel). 2019; 11(11). PMC: 6893780. DOI: 10.3390/cancers11111626. View

Xu Y, Wang S, Chen Z, Hu R, Li S, Zhao Y . Highly stable organic photothermal agent based on near-infrared-II fluorophores for tumor treatment. J Nanobiotechnology. 2021; 19(1):37. PMC: 7863535. DOI: 10.1186/s12951-021-00782-y. View

Yau T, Tai D, Chan S, Huang Y, Choo S, Hsu C . Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan. Liver Cancer. 2022; 11(5):426-439. PMC: 9485972. DOI: 10.1159/000525582. View

Yang C, Zhang H, Zhang L, Zhu A, Bernards R, Qin W . Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022; 20(4):203-222. DOI: 10.1038/s41575-022-00704-9. View

Kamkaew A, Lim S, Lee H, Kiew L, Chung L, Burgess K . BODIPY dyes in photodynamic therapy. Chem Soc Rev. 2012; 42(1):77-88. PMC: 3514588. DOI: 10.1039/c2cs35216h. View

10.

Cao C, Yang N, Dai H, Huang H, Song X, Zhang Q . Recent advances in phase change material based nanoplatforms for cancer therapy. Nanoscale Adv. 2022; 3(1):106-122. PMC: 9419072. DOI: 10.1039/d0na00622j. View

11.

Yan P, Shu X, Zhong H, Chen P, Gong H, Han S . A versatile nanoagent for multimodal imaging-guided photothermal and anti-inflammatory combination cancer therapy. Biomater Sci. 2021; 9(14):5025-5034. DOI: 10.1039/d1bm00576f. View

12.

Mocan T, Matea C, Cojocaru I, Ilie I, Tabaran F, Zaharie F . Photothermal Treatment of Human Pancreatic Cancer Using PEGylated Multi-Walled Carbon Nanotubes Induces Apoptosis by Triggering Mitochondrial Membrane Depolarization Mechanism. J Cancer. 2014; 5(8):679-88. PMC: 4174512. DOI: 10.7150/jca.9481. View

13.

Xu P, Liang F . Nanomaterial-Based Tumor Photothermal Immunotherapy. Int J Nanomedicine. 2020; 15:9159-9180. PMC: 7684030. DOI: 10.2147/IJN.S249252. View

13.

Wen J, Xue L, Wei Y, Liang J, Jia W, Yong T . YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA Axis. Adv Sci (Weinh). 2024; 11(13):e2307242. PMC: 10987122. DOI: 10.1002/advs.202307242. View

14.

Zhou F, Wang H, Chang J . Progress in the Field of Constructing Near-Infrared Light-Responsive Drug Delivery Platforms. J Nanosci Nanotechnol. 2016; 16(3):2111-25. DOI: 10.1166/jnn.2016.10945. View

15.

Li X, Lovell J, Yoon J, Chen X . Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020; 17(11):657-674. DOI: 10.1038/s41571-020-0410-2. View

16.

Jaque D, Martinez Maestro L, del Rosal B, Haro-Gonzalez P, Benayas A, Plaza J . Nanoparticles for photothermal therapies. Nanoscale. 2014; 6(16):9494-530. DOI: 10.1039/c4nr00708e. View

16.

Jedrzak A, Grzeskowiak B, Golba K, Coy E, Synoradzki K, Jurga S . Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro. Int J Nanomedicine. 2020; 15:7923-7936. PMC: 7569049. DOI: 10.2147/IJN.S257142. View

17.

Overchuk M, Weersink R, Wilson B, Zheng G . Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine. ACS Nano. 2023; 17(9):7979-8003. PMC: 10173698. DOI: 10.1021/acsnano.3c00891. View